Doxycycline Hyclate Tablets USP — Class II drug recall D-1274-2020
Terminated recall by West-Ward Columbus Inc, reported 2020-06-03, distributed nationwide. Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded
| Recall number | D-1274-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | West-Ward Columbus Inc, Columbus, OH, United States |
| Recall initiated | 2020-05-13 |
| Classified | 2020-05-26 |
| Reported by FDA | 2020-06-03 |
| Terminated | 2023-03-25 |
| Distributed | Nationwide (US) |
| Quantity | 68,376 bottles |
| Reason classes | specification failure |
| NDC | 00143-2112, 00143-2112-05, 00143-2112-20, 00143-2112-50 |
| Expiration dates | 2020-06, 2021-06 |
Product
Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 500-count bottle (NDC 0143-2112-05), Rx only, Mfd. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724.
Reason for recall
Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1274-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.